Disclosure Of Interests In Other Entities [Text Block]

Medistim - Filing #5830287

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	—	—	—	—	—	—	—	429 131 NOK	—	—	391 566 NOK	—	—	—	—	—	—	—	—
Non-current assets	—	—	—	—	—	—	—	—	—	145 837 NOK	—	—	114 152 NOK	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	—	—	—	—	—	—	107 367 NOK	—	—	94 284 NOK	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	—	—	—	—	—	—	—	30 990 NOK	—	—	13 493 NOK	—	—	—	—	—	—	—	—
Revenue	—	—	—	—	—	556 164 NOK	—	—	—	—	521 109 NOK	—	—	—	—	—	—	—	—	—	—
Profit (loss)	—	—	—	—	—	103 832 NOK	—	—	—	—	103 823 NOK	—	—	—	—	—	—	—	—	—	—
Comprehensive income	- NOK	16 184 NOK	- NOK	- NOK	103 832 NOK	120 016 NOK	- NOK	- NOK	120 016 NOK	—	106 420 NOK	- NOK	—	2 597 NOK	103 823 NOK	- NOK	- NOK	- NOK	106 420 NOK	- NOK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	—	—	—	—	—	—	179 210 NOK	—	—	153 872 NOK	—	—	—	—	—	—	—	152 641 NOK
Depreciation and amortisation expense	—	—	—	—	—	24 510 NOK	—	—	—	—	23 657 NOK	—	—	—	—	—	—	—	—	—	—
Tax expense (income)	—	—	—	—	—	30 414 NOK	—	—	—	—	31 389 NOK	—	—	—	—	—	—	—	—	—	—